SBLATTERO, DANIELE
 Distribuzione geografica
Continente #
NA - Nord America 12.402
EU - Europa 4.938
AS - Asia 2.129
SA - Sud America 31
Continente sconosciuto - Info sul continente non disponibili 22
AF - Africa 16
OC - Oceania 3
Totale 19.541
Nazione #
US - Stati Uniti d'America 12.375
PL - Polonia 986
SE - Svezia 933
UA - Ucraina 799
IT - Italia 765
CN - Cina 649
SG - Singapore 550
HK - Hong Kong 531
FI - Finlandia 322
TR - Turchia 296
DE - Germania 229
BG - Bulgaria 164
RU - Federazione Russa 163
IE - Irlanda 160
GB - Regno Unito 141
FR - Francia 87
BE - Belgio 44
CA - Canada 25
CH - Svizzera 25
BR - Brasile 22
NL - Olanda 22
EU - Europa 20
ES - Italia 19
VN - Vietnam 18
IN - India 16
KR - Corea 15
JP - Giappone 14
HU - Ungheria 13
CZ - Repubblica Ceca 12
SN - Senegal 12
AT - Austria 10
IR - Iran 8
HR - Croazia 7
RO - Romania 7
GR - Grecia 6
DK - Danimarca 5
ID - Indonesia 5
IQ - Iraq 5
MY - Malesia 5
PT - Portogallo 5
BD - Bangladesh 4
CO - Colombia 4
CL - Cile 3
NO - Norvegia 3
PK - Pakistan 3
SI - Slovenia 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AR - Argentina 2
AU - Australia 2
IL - Israele 2
LV - Lettonia 2
MX - Messico 2
SA - Arabia Saudita 2
TW - Taiwan 2
AZ - Azerbaigian 1
BY - Bielorussia 1
EE - Estonia 1
EG - Egitto 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
NZ - Nuova Zelanda 1
Totale 19.541
Città #
Woodbridge 1.543
Fairfield 1.441
Ann Arbor 1.372
Houston 1.340
Warsaw 979
Chandler 935
Ashburn 855
Jacksonville 733
Wilmington 690
Seattle 626
Hong Kong 530
Cambridge 482
Singapore 468
Princeton 308
Boardman 280
Trieste 280
Izmir 274
Beijing 178
Sofia 163
Dublin 160
Columbus 154
Moscow 112
Dearborn 85
San Diego 71
Milan 70
Helsinki 69
Santa Clara 65
Munich 62
Bremen 56
Düsseldorf 44
Falls Church 43
Brussels 42
Jinan 42
Des Moines 36
Nanjing 32
Buffalo 27
Norwalk 26
Sacile 24
Chicago 23
Hefei 23
Shanghai 23
Washington 23
Verona 21
Bern 20
Guangzhou 20
Dong Ket 18
Kunming 17
Fremont 16
Shenyang 16
Denver 15
Mestre 15
Redwood City 15
Phoenix 14
Toronto 14
Dakar 12
Dallas 12
Redmond 12
Brno 11
Gothenburg 11
Budapest 10
Seoul 10
Tokyo 10
Los Angeles 9
San Francisco 9
Vienna 9
Auburn Hills 8
Edinburgh 8
Kocaeli 8
Port Coquitlam 8
São Paulo 8
Torre Del Greco 8
Changsha 7
Fuzhou 7
Hebei 7
London 7
Pune 7
Tulsa 7
Wuhan 7
Zhengzhou 7
Amsterdam 6
Cascina 6
Chongqing 6
Detroit 6
Leawood 6
Nanchang 6
Philadelphia 6
Seville 6
Tappahannock 6
Andover 5
Boston 5
Chengdu 5
Frankfurt am Main 5
Grafing 5
Hangzhou 5
Taizhou 5
Tianjin 5
Wolnzach 5
Zagreb 5
Aarhus 4
Ankara 4
Totale 15.321
Nome #
SINEUPs are modular antisense long non-coding RNAs that increase synthesis of target proteins in cells 339
Targeted delivery of neutralizing anti-C5 antibody to renal endothelium prevents complement- dependent tissue damage 316
Tissue transglutaminase (TG2) enables survival of human malignant pleural mesothelioma cells in hypoxia 309
Rational design of antirheumatic prodrugs specific for sites of inflammation 300
Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice. 260
A non-complement-fixing antibody to  2 glycoprotein I as a novel therapy for antiphospholipid syndrome 234
Testing for Anti-Human Transglutaminase Antibodies in Saliva Is Not Useful for Diagnosis of Celiac Disease 220
Selecting soluble/foldable protein domains through single-gene or genomic ORF filtering: structure of the head domain of Burkholderia pseudomallei antigen BPSL2063 216
Looking for celiac disease: diagnostic accuracy of two rapid commercial assays 216
Anti-transglutaminase antibodies and age. 200
Autoantibodies as predictors of disease. 194
The Use of Biopsy and "no-Biopsy" Approach for Diagnosing Paediatric Coeliac Disease in the Central European Region 193
Diagnostic Delays in Children with Coeliac Disease in the Central European Region 189
Analyzing the peripheral blood antibody repertoire of a celiac disease patient using phage antibody libraries 187
An Albumin-Derived Peptide Scaffold Capable of Binding and Catalysis 187
The gut as site of production of autoimmune antibodies. 185
Anti transglutaminase antibodies cause ataxia in mice. 183
SINEUPs: A new class of natural and synthetic antisense long non-coding RNAs that activate translation 183
Recombinant antibody selections by combining phage and yeast display 181
Using archaeal histones for precise DNA fragmentation , 20: 267-271 (2007) 180
Role of anti-osteopontin antibodies in multiple sclerosis and experimental autoimmune encephalomyelitis 178
Phage display technology for human monoclonal antibodies 175
Construction of miniantibodies for the in vivo study of human autoimmune diseases in animal models 169
One-step cloning of anti tissue transglutaminase scFv from subjects with celiac disease. 169
Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59 167
null 166
Primer sets for cloning the human repertoire of T cell Receptor variable regions 166
A reliable screening procedure for coeliac disease in clinical practice. 165
null 163
Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease. 158
Molecular dissection of the tissue transglutaminase auto-antibody response in celiac disease 156
Dual sugar gut-permeability testing on blood drop in animal models. 155
The analysis of the fine specificity of celiac disease antibodies using tissue transglutaminase fragments 154
Interactome-Seq: A Protocol for Domainome Library Construction, Validation and Selection by Phage Display and Next Generation Sequencing 151
Development of a novel rapid non-invasive screening test for coeliac disease. 149
Prevention of arthritis by locally synthesized recombinant antibody neutralizing complement component C5 149
Extending filamentous phage host range by the grafting of a heterologous receptor binding domain 147
Antibodies in haystacks: how selection strategy influences the outcome of selection from molecular diversity libraries 147
Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease 147
An Air-well sparging minifermenter system for high-throughput protein production 147
Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease 146
N-glycosylation of the mammalian dipeptidyl aminopeptidase-like protein 10 (DPP10) regulates trafficking and interaction with Kv4 channels 146
Characterization of the anti-tissue transglutaminase antibody response in nonobese diabetic mice. 143
Targeting CD34+ cells of the inflamed synovial endothelium by guided nanoparticles for the treatment of rheumatoid arthritis 141
Mapping the minimum domain of the fibronectin binding site on transglutaminase 2 (TG2) and its importance in mediating signaling, adhesion, and migration in TG2-expressing cells 141
Profiling the Autoantibody Repertoire by Screening Phage-Displayed Human cDNA Libraries 139
A novel quantitative ELISA as accurate and reproducible tool to detect epidermal transglutaminase antibodies in patients with Dermatitis Herpetiformis 139
Antibodies in proteomics I: generating antibodies 138
Antibodies in proteomics II: screening, high-throughput characterization and downstream applications 138
Gluten ataxia: passive transfer in a mouse model. 138
Differential induction of IL-17, IL-10, and IL-9 in human T helper cells by B7h and B7.1 138
A Functional Idiotype/Anti-Idiotype Network Is Active in Genetically Gluten-Intolerant Individuals Negative for Both Celiac Disease-Related Intestinal Damage and Serum Autoantibodies 138
A label-free immunoassay for Flavivirus detection by the Reflective Phantom Interface technology 137
A definitive set of oligonucleotide primers for amplifying human V regions 136
Impaired glycosylation blocks DPP10 cell surface expression and alters the electrophysiology of i to channel complex 136
Plasmid incompatibility: More compatible than previously thought? 135
Anti-idiotypic response in mice expressing human autoantibodies. 132
Mass screening for coeliac disease using antihuman transglutaminase antibody assay. 131
Celiac disease in patients with sporadic and inherited cardiomyopathies and in their relatives. 130
Majority of children with type 1 diabetes produce and deposit anti-tissue transglutaminase antibodies in the small intestine. 130
Prevalence of celiac disease among risk groups and the general population in USA 130
Treatment of experimental arthritis by targeting synovial endothelium with a neutralizing recombinant antibody to C5. 130
Anti-tissue transglutaminase antibodies activate intracellular tissue transglutaminase by modulating cytosolic Ca2+ homeostasis 130
A Human Monoclonal Antibody Against Domain I Of beta 2-Glycoprotein I prevents Clotting and Fetal Loss Induced By Polyclonal Anti-Phospholipid Antibodies In Animal Models. 130
Engineering mammalian cell factories with SINEUP noncoding RNAs to improve translation of secreted proteins 127
In vivo recombination as a tool to generate molecular diversity in phage antibody libraries 126
Cloning and characyerization of intestinal antibodies to tissue transglutaminase in celiac disease patients 124
A deep-blue OLED-based biochip for protein microarray fluorescence detection 123
Celiac anti-tissue transglutaminase antibodies interfere with the uptake of alpha gliadin peptide 31-43 but not of peptide 57-68 by epithelial cells 123
Filtering "genic" open reading frames from genomic DNA samples for advanced annotation 122
Selection and characterization of a novel agonistic human recombinant anti-TRAIL-R2 minibody with anti-leukemic activity. 121
Recombinant renewable polyclonal antibodies 120
null 119
Triggering of B7h by the ICOS modulates maturation and migration of monocyte-derived dendritic cells 119
RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies 118
Transglutaminase 2-specific coeliac disease autoantibodies induce morphological changes and signs of inflammation in the small-bowel mucosa of mice 118
Human tissue transglutaminase ELISA: powerful massscreening diagnostic assay for coeliac disease 117
Rapid and simple dot immunobinding assay to detect anti human transglutaminase antibodies in coeliac disease 117
Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor. 117
Profiling celiac disease antibody repertoire 117
A single conformational transglutaminase 2 epitope contributed by three domains is critical for celiac antibody binding and effects 117
The transmembrane β-subunits KCNE1, KCNE2, and DPP6 modify pharmacological effects of the antiarrhythmic agent tedisamil on the transient outward current i to 117
Binders based on dimerised immunoglobulin VH domains 115
Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia 115
Antibodies to transglutaminasefrom phage display libraries 114
null 114
Protective role of anti-idiotypic network in celiac disease prone subjects 113
Usefulness of gluten-free diet in gluten-genetically predisposed subjects positive to intestinal mucosa anti-transglutaminase antibodies 112
Increasing titres of anti-human-transglutaminase antibodies with age in healthy population 111
Mucosal tissue transglutaminase expression in celiac disease 110
Antibodies against breain structures in a celiac patient with ataxic syndrome are produced in the intestine 108
A zonulin-occludens toxin synthetic esapeptide modifies the intestinal permeabilità in in-vivo animal model 107
DEVELOPMENT OF CHLORAMBUCIL/HYDROXYCHLOROQUINE-LOADED ANTI-CD20 NANOPARTICLES FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA : IN VITRO MODEL 107
Celiac anti-type 2 transglutaminase antibodies induce phosphoproteome modification in intestinal epithelial caco-2 cells 106
Characterizing monoclonal antibody epitopes by filtered gene fragment phagedisplay. 105
Usefulness of gluten-free diet in gluten-genetically predisposed subjects positive to intestinal-mucosa anti-transglutaminase antibodies 105
Protective role of anti-idiotypic network in celiac disease prone subjects 105
Site of syntesis of antibodies to A-gliadin and tissue-transglutaminase in celiac disease patients 105
Anti-alpha enolase autoantibodies in coeliac disease 104
Anti tTG autoantibodies crossreacting with brain structures are produced in the intestine in celiac patient with equilibrium disorder 104
Totale 15.044
Categoria #
all - tutte 55.762
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.762


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.821 0 0 0 0 0 0 411 447 347 227 263 126
2020/20212.608 256 177 259 309 203 275 144 218 143 275 104 245
2021/20221.699 86 114 68 138 65 155 74 55 206 177 139 422
2022/20232.648 253 328 213 379 265 483 26 238 285 25 115 38
2023/20241.458 80 78 72 93 154 192 222 271 22 36 132 106
2024/20251.602 40 159 256 319 376 440 12 0 0 0 0 0
Totale 20.036